145 related articles for article (PubMed ID: 27654640)
1. Expressions of urothelial functional proteins in idiopathic detrusor overactivity patients refractory to antimuscarinic therapy with different urodynamic characteristics.
Liu HT; Kuo HC
Neurourol Urodyn; 2017 Jun; 36(5):1313-1319. PubMed ID: 27654640
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.
Mansfield KJ; Liu L; Moore KH; Vaux KJ; Millard RJ; Burcher E
BJU Int; 2007 Jun; 99(6):1433-8. PubMed ID: 17428242
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder.
Di Salvo J; Nagabukuro H; Wickham LA; Abbadie C; DeMartino JA; Fitzmaurice A; Gichuru L; Kulick A; Donnelly MJ; Jochnowitz N; Hurley AL; Pereira A; Sanfiz A; Veronin G; Villa K; Woods J; Zamlynny B; Zycband E; Salituro GM; Frenkl T; Weber AE; Edmondson SD; Struthers M
J Pharmacol Exp Ther; 2017 Feb; 360(2):346-355. PubMed ID: 27965369
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with a β
Imamura T; Ogawa T; Minagawa T; Nagai T; Suzuki T; Saito T; Yokoyama H; Nakazawa M; Ishizuka O
Neurourol Urodyn; 2017 Apr; 36(4):1026-1033. PubMed ID: 27367573
[TBL] [Abstract][Full Text] [Related]
5. Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.
McKeage K
Clin Drug Investig; 2013 Jan; 33(1):71-91. PubMed ID: 23288694
[TBL] [Abstract][Full Text] [Related]
6. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury.
Chen SF; Jiang YH; Kuo HC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):125-133. PubMed ID: 29482913
[TBL] [Abstract][Full Text] [Related]
7. Changes in sensory proteins in the bladder urothelium of patients with chronic kidney disease and end-stage renal disease.
Chen SF; Lee CL; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O202-O208. PubMed ID: 30198096
[TBL] [Abstract][Full Text] [Related]
8. Urothelial Barrier Deficits, Suburothelial Inflammation and Altered Sensory Protein Expression in Detrusor Underactivity.
Jiang YH; Kuo HC
J Urol; 2017 Jan; 197(1):197-203. PubMed ID: 27436428
[TBL] [Abstract][Full Text] [Related]
9. Urothelial Dysfunction, Suburothelial Inflammation and Altered Sensory Protein Expression in Men with Bladder Outlet Obstruction and Various Bladder Dysfunctions: Correlation with Urodynamics.
Jiang YH; Lee CL; Kuo HC
J Urol; 2016 Sep; 196(3):831-7. PubMed ID: 26930253
[TBL] [Abstract][Full Text] [Related]
10. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
Kuo HC
Neurourol Urodyn; 2011 Sep; 30(7):1242-8. PubMed ID: 21560152
[TBL] [Abstract][Full Text] [Related]
11. Additive effects of intravenous and intravesical application of vibegron, a β
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2073-2080. PubMed ID: 32556396
[TBL] [Abstract][Full Text] [Related]
12. Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M
Hara H; Imamura T; Suzuki A; Ueno M; Minagawa T; Ogawa T; Ishizuka O
Low Urin Tract Symptoms; 2023 Mar; 15(2):68-75. PubMed ID: 36543093
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
[TBL] [Abstract][Full Text] [Related]
14. Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.
Birder LA; Wolf-Johnston AS; Sun Y; Chai TC
Acta Physiol (Oxf); 2013 Jan; 207(1):123-9. PubMed ID: 22691178
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration.
Datta SN; Roosen A; Pullen A; Popat R; Rosenbaum TP; Elneil S; Dasgupta P; Fowler CJ; Apostolidis A
J Urol; 2010 Dec; 184(6):2578-85. PubMed ID: 21030043
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity.
Casanova N; McGuire E; Fenner DE
Int J Gynaecol Obstet; 2006 Dec; 95(3):305-11. PubMed ID: 17070528
[TBL] [Abstract][Full Text] [Related]
17. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
Andersson KE
Int J Clin Pract Suppl; 2006 Dec; (151):8-16. PubMed ID: 17169005
[TBL] [Abstract][Full Text] [Related]
18. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
Chen SF; Chang CH; Kuo HC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity.
Liu HT; Kuo HC
BJU Int; 2007 Nov; 100(5):1086-90. PubMed ID: 17711510
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: a single-blind study.
Schulte-Baukloh H; Priefert J; Knispel HH; Lawrence GW; Miller K; Neuhaus J
Urology; 2013 May; 81(5):1052-7. PubMed ID: 23419459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
